New Results
Clinical Impact and Cost-Effectiveness of a 176-Condition Expanded Carrier Screen
View ORCID ProfileKyle A. Beauchamp, View ORCID ProfileKatherine A. Johansen Taber, View ORCID ProfileDale Muzzey
doi: https://doi.org/10.1101/372334
Kyle A. Beauchamp
aCounsyl. South San Francisco, CA. 94080
PhDKatherine A. Johansen Taber
aCounsyl. South San Francisco, CA. 94080
PhDDale Muzzey
aCounsyl. South San Francisco, CA. 94080
PhDArticle usage
Posted July 24, 2018.
Clinical Impact and Cost-Effectiveness of a 176-Condition Expanded Carrier Screen
Kyle A. Beauchamp, Katherine A. Johansen Taber, Dale Muzzey
bioRxiv 372334; doi: https://doi.org/10.1101/372334
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)